Overview
Nusayba Bagegni is a Hematologist in Saint Louis, Missouri. Dr. Bagegni is highly rated in 6 conditions, according to our data. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer.
Her clinical research consists of co-authoring 18 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- PPO
- EPO
- HMO
- PPO
- EPO
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- INSURANCE PLAN
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- OTHER COMMERCIAL
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
4921 Parkview Pl Fl 7, Saint Louis, MO 63110
10 Barnes West Dr Ste 100, Saint Louis, MO 63141
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
10 Clinical Trials
Office
Brad Kahl is a Hematologist in Saint Louis, Missouri. Dr. Kahl is highly rated in 28 conditions, according to our data. His top areas of expertise are Mantle Cell Lymphoma (MCL), Follicular Lymphoma, Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Splenectomy.
Office
Neha Mehta is a Hematologist in Saint Louis, Missouri. Dr. Mehta has been practicing medicine for over 17 years is highly rated in 23 conditions, according to our data. Her top areas of expertise are Peripheral T-Cell Lymphoma, T-Cell Lymphoma, Non-Hodgkin Lymphoma, Cutaneous T-Cell Lymphoma (CTCL), and Bone Marrow Aspiration.
Office
Ravi Vij is a Hematologist in Saint Louis, Missouri. Dr. Vij is highly rated in 20 conditions, according to our data. His top areas of expertise are Multiple Myeloma, Acute Myeloid Leukemia (AML), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Frequently Asked Questions about Dr. Nusayba Bagegni
How do I make an appointment with Dr. Nusayba Bagegni?
You can book an appointment with Dr. Nusayba Bagegni by calling their office at 314-747-1171. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Nusayba Bagegni a top-rated expert for Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Nusayba Bagegni is classified as an Distinguished expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Nusayba Bagegni specialize in?
While Dr. Nusayba Bagegni is a Hematology, they have specific expertise in Breast Cancer, Paget Disease of the Breast, and Angiosarcoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Nusayba Bagegni participate in research or clinical trials?
Yes. Dr. Nusayba Bagegni has published 18 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Nusayba Bagegni's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Nusayba Bagegni accept my insurance?
Dr. Nusayba Bagegni accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 314-747-1171 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- AngiosarcomaDr. Bagegni isDistinguished. Learn about Angiosarcoma.
- Breast CancerDr. Bagegni isDistinguished. Learn about Breast Cancer.
- Paget Disease of the BreastDr. Bagegni isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- HER-2 Positive Breast CancerDr. Bagegni isAdvanced. Learn about HER-2 Positive Breast Cancer.
- Inflammatory Breast CancerDr. Bagegni isAdvanced. Learn about Inflammatory Breast Cancer.
- Triple-Negative Breast CancerDr. Bagegni isAdvanced. Learn about Triple-Negative Breast Cancer.
- Experienced
- AgranulocytosisDr. Bagegni isExperienced. Learn about Agranulocytosis.
- Breast Cancer in MenDr. Bagegni isExperienced. Learn about Breast Cancer in Men.
- Chronic Familial NeutropeniaDr. Bagegni isExperienced. Learn about Chronic Familial Neutropenia.
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Bagegni isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Fibrolamellar CarcinomaDr. Bagegni isExperienced. Learn about Fibrolamellar Carcinoma.
- Large-Cell Immunoblastic LymphomaDr. Bagegni isExperienced. Learn about Large-Cell Immunoblastic Lymphoma.